Immunophenotypic characterization of acute leukemia at a public oncology reference center in Maranhão, northeastern Brazil
Keywords:
Precursor cell lymphoblastic leukemialymphoma, Leukemia, myeloid, acute, Prevalence, Immunophenotyping, PrognosisAbstract
CONTEXT AND OBJECTIVES: The incidence of acute leukemia (AL) subtypes varies according to geographical distribution. The aim here was to determine the incidence of morphological and immunophenotypic AL subtypes in the state of Maranhão, Brazil, and to correlate the expression of aberrant phenotypes in children with acute lymphoblastic leukemia (ALL) with prognostic factors. DESIGN AND SETTING: Single prospective cohort study at a public oncology reference center in Maranhão. METHODS: Seventy AL cases were diagnosed between September 2008 and January 2010. For the diagnosis, complete blood cell counts, myelograms (at diagnosis and at the end of the induction phase), cytochemical analysis and immunophenotyping were performed. RESULTS: Among adult patients (n = 22), the incidence of AL types was: ALL (22.7%) and acute myeloid leukemia (AML) (77.3%). The subtype AML M0 occurred most frequently (29.4%). In children (n = 48), the types were: AML (18.7%), most frequently subtype AML M4 (33.4%); biphenotypic acute leukemia (BAL) (4.2%); and ALL (77.1%), including the subtypes B-ALL (72.9%) and T-ALL (27.1%). Among the children with ALL, there were no statistically significant differences between patients with and without aberrant phenotypes, in relation to hematological parameters and treatment response. CONCLUSION: This work demonstrates that the frequencies of AML M0 cases among adults and T-ALL cases among children in Maranhão were high. This suggests that there may be differences in AML subtype incidence, as seen with ALL subtypes, in different regions of Brazil. No association was found between the expression of aberrant phenotypes and prognostic factors, in children with ALL.
Downloads
References
McCulloch EA. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood. 1983;62(1):1-13.
Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(4):655-74.
Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med. 2004;350(15):1535-48.
Killick S, Matutes E, Powles RL, et al. Outcome of biphenotypic acute leukemia. Haematologica. 1999;84(8):699-706.
Lee PS, Lin CN, Liu C, Huang CT, Hwang WS. Acute leukemia with myeloid, B-, and natural killer cell differentiation. Arch Pathol Lab Med. 2003;127(2):E93-5.
Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783-6.
The value of c-kit in the diagnosis of biphenotypic acute leukemia. EGIL (European Group for the Immunological Classification of Leukaemias). Leukemia. 1998;12(12):2038.
Bhushan B, Chauhan PS, Saluja S, et al. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome. Clin Exp Med. 2010; 10(1):33-40.
Szczepański T, van der Velden VH, van Dongen JJ. Classification systems for acute and chronic leukaemias. Best Pract Res Clin Haematol. 2003;16(4):561-82.
Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941-67.
Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: World Health Organization/IARC Press; 2001.
Groves FD, Linet MS, Devesa SS. Patterns of occurrence of the leukaemias. Eur J Cancer. 1995;31A(6):941-9.
Pombo-de-Oliveira MS, Cordoba JC, Alencar DM, et al. Biological diversity variations of pediatric acute leukemia in Brazil: contribution of immunophenotypic profiles to epidemiological studies. Rev Bras Hematol Hemoter. 2005;27(1):21-6.
Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451-8.
Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103(4):620-5.
Bennett JM, Catovsky D, Daniel MT, et al. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol. 1991;78(3):325-9.
oncopediatria.org. Protocolo GBTLI LLA-99. Objetivos. Available from: http://www.oncopediatria.org.br/portal/artigos/profissionais/protocolos/lla99.jsp. Acessed in 2011 (Apr 6).
Rego MFN, Pinheiro, GS, Metze K, Lorand-Metze I. Acute leukemias in Piauí: comparison with features observed in other regions of Brazil. Braz J Med Biol Res = Rev Bras Pesqui M D Biol. 2003;36(3):331-7.
Knox-Macaulay HH, Brown LC. Descriptive epidemiology of de novo acute leukaemia in the Sultanate of Oman. Leuk Res. 2000; 24(7):589-94.
Leite EP, Muniz MTC, Azevedo ACAC, et al. Fatores prognósticos em crianças e adolescentes com Leucemia Linfóide Aguda [Prognostic factors in children and adolescents with Acute Lymphoblastic Leukemia]. Rev Bras Saúde Matern Infant. 2007;7(4):413-21.
Rego EM, Garcia AB, Viana SR, Falcão RP. Characterization of acute lymphoblastic leukemia subtypes in Brazilian patients. Leuk Res. 1996;20(4):349-55.
Pombo de Oliveira MS, Koifman S, Vasconcelos GM, et al. Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia. Blood Cells Mol Dis. 2009;42(2):121-5.
Bachir F, Bennani S, Lahjouji A, et al. Characterization of acute lymphoblastic leukemia subtypes in moroccan children. Int J Pediatr. 2009;2009:674801.
Rajalekshmy KR, Abitha AR, Pramila R, Gnanasagar T, Shanta V. Immunophenotypic analysis of T-cell acute lymphoblastic leukaemia in Madras, India. Leuk Res. 1997;21(2):119-24.
Paes CA, Viana MB, Freire RV, et al. Direct association of socio-economic status with T-cell acute lymphoblastic leukaemia in children. Leuk Res. 2003;27(9):789-94.
Barreto FA, Manso CA, França JM, Maros PF, Santos A. Relatório de Pesquisa no 6. Quais os estados brasileiros que obtiveram os melhores desempenhos? Fortaleza: Universidade Federal do Ceará; 2009. Available from: http://www.caen.ufc.br/~lep/relatorios/rp6.pdf. Acessed in 2011 (Apr 29).
Brasil. Ministério do Planejamento, Orçamento e Gestão. Instituto Brasileiro de Geografia e Estatística - IBGE. Diretoria de Pesquisas. Coordenação de População e Indicadores Sociais. Estudos e Pesquisas. Informação Demográfica e Socioeconômica. Síntese de Indicadores Sociais. Uma análise das condições de vida da população brasileira 2010. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2010. Available from: http://www.ibge.gov.br/home/estatistica/populacao/condicaodevida/indicadoresminimos/sinteseindicsociais2010/SIS_2010.pdf. Acessed in 2011 (Apr 29).
Estey E, Döhner H. Acute myeloid leukaemia. Lancet. 2006; 368(9550):1894-907.
Chang H, Salma F, Yi QL, et al. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leuk Res. 2004;28(1):43-8.
Al-Mawali A, Gillis D, Hissaria P, Lewis I. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry. Am J Clin Pathol. 2008;129(6):934-45.
Pulcheri W, Spector N, Nucci M, et al. The treatment of acute myeloid leukemia in Brazil: progress and obstacles. Haematologica. 1995;80(2):130-5.
Bittencourt R, Fogliato L, Daudt L, et al. Leucemia Mielóide Agura: perfil de duas décadas do Serviço de Hematologia do Hospital das Clínicas de Porto Alegre - RS [Acute Myelogenous Leukemia: two decades overview - Hematology Service Hospital de Clínicas de Porto Alegre – RS]. Rev Bras Hematol Hemoter. 2003;25(1):17-24.
Zanichelli MA, Cristófani LM, Almeida MTA, Maluf Júnior PT, Odone Filho V. Perspectivas para a leucemia mielóide aguda na infância após a observação de um grupo de pacientes tratados convencionalmente [Pediatric acute myeloid leukemia outcomes after conventional treatment]. Rev Bras Hematol Hemoter. 2006;28(4):246-52.
Viana MB, Cunha KCCMS, Ramos G, Murao M. Leucemia mielóide aguda na criança: experiência de 15 anos em uma única instituição [Acute myeloid leukemia in childhood: a fifteen-year experience in a single institution]. J Pediatr (Rio J). 2003;79(6):489-96.
Creutzig U, Harbott J, Sperling C, et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood. 1995;86(8):3097-108.
Kotylo PK, Seo IS, Smith FO, et al. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). Am J Clin Pathol. 2000;113(2):193-200.
Callera F, Mulin CC, Rosa ES, Melo DB, Melo CM. High prevalence of morphological subtype FAB M1 in adults with de novo acute myeloid leukemia in São José dos Campos, São Paulo. Sao Paulo Med J. 2006;124(1):45-7.
Suárez L, Vidriales MB, García-Laraña J, et al. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Clin Cancer Res. 2004;10(22):7599-606.
Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data. Arch Pathol Lab Med. 2003;127(1):42-8.
Putti MC, Rondelli R, Cocito MG, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood. 1998;92(3):795-801.
Den Boer ML, Kapaun P, Pieters R, et al. Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance. Br J Haematol. 1999;105(4):876-82.
Abdelhaleem M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp Mol Pathol. 2007;83(1):138-41.
Zheng J, Wang X, Hu Y, et al. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Cytometry B Clin Cytom. 2008;74(1):25-9.
Pui CH, Behm FG, Singh B, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood. 1990;75(1):198-202.
Riley RS, Massey D, Jackson-Cook C, Idowu M, Romagnoli G. Immunophenotypic analysis of acute lymphocytic leukemia. Hematol Oncol Clin North Am. 2002;16(2):245-99, v.
